Conditions: Depressive Disorder, Major
Keywords: Major Depressive Disorder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 437
Healthy volunteers: no

Brief summary:
This is a multicenter study to assess the health and well-being in subjects who are outpatients with major depressive disorder that take desvenlafaxine succinate sustained release (DVS SR) or placebo for 12 weeks.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: desvenlafaxine succinate sustained release intervention 2: Genotyping
Intervention descriptions: intervention 1: 50 mg/day oral tablet for 12 weeks intervention 2: CYP2D6 genotyping at randomization

Protocol document: